Paula M. Castano, MD, MPH
Overview
I am proud to support my patients in making the reproductive health decisions that are right for them.
Paula Castaño, MD, MPH, is a board certified obstetrician gynecologist. She received an undergraduate degree at Brown University and completed medical school at the University of Minnesota. She was a resident at the University of Texas Southwestern Parkland Memorial Hospital in Dallas. Dr. Castaño completed her fellowship in family planning at Columbia University Medical Center, where she also obtained a Master of Public Health in Epidemiology. Her clinical focus is on office-based procedures. Her research interests include contraceptive use by HIV-infected women, the folate status of reproductive-aged women, and the use of technology to improve contraceptive continuation. She serves as director of the Faculty Practice.
Areas of Expertise / Conditions Treated
- Colposcopy
- Contraceptive Care
- Family Planning
- Hysteroscopic Polypectomy/Myomectomy
- Intrauterine Device (IUD) and Contraceptive Implant Placements and Removals
- LEEP (Loop Electrosurgical Excision Procedure)
- Menstrual Disorders
- Miscarriage Management
- Routine Gynecologic Care
- Sterilization
Academic Appointments
- Associate Professor of Obstetrics & Gynecology at CUMC
Administrative Titles
- Medical Director, Outpatient Services
- Medical Director, Columbus Circle Practice
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Languages
- Spanish
Gender
- Female
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Signature Administrators
- Student Health
AgeWell
- Medicare Managed Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
Credentials & Experience
Education & Training
- University of Minnesota Medical School
- Residency: University of Texas Southwestern Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Gynecology
- Obstetrics and Gynecology
Honors & Awards
- Organon Inc. Resident Research Award Outstanding Research in Women’s Health
Research
Grants
BLOC: PROSPECTIVE MULTI-CENTER OFFICE BASED BI-LATERAL TUBAL OCCLUSION TRIAL FOR FEMALE PERMANENT CONTRACEPTION (P&S Industry Clinical Trial)
Oct 30 2018 - Oct 30 2023
ANOPEN-LABEL, NON-RANDOMIZED, PROSPECTIVE OBSERVATIONAL COHORT STUDY TO ASSESS POST-PROCEDURAL OUTCOMES IN TWO COHORTS OF WOMEN WHO CHOSE TO UNDERGO EITHER HYSTEROSCOPIC STERILIZATION (ESSURE) OR LAPROSCOPIC TUBAL STERLIZATION (P&S Industry Clinical Trial)
Nov 15 2017 - Nov 15 2022
PILOT BI-LATERAL TUBAL OCCLUSION TRIAL FOR FEMALE PERMANENT CONTRACEPTION (P&S Industry Clinical Trial)
Mar 8 2017 - Mar 8 2022
CORE FUNCTION ACTIVITIES (Federal Gov)
Jun 26 2013 - Jun 25 2020
ASINGLE-ARM, OPEN-LABEL, MULTICENTER PHASE 3 STUDY OF THE CONTRACEPTIVE EFFICACY, SAFETY AND TOLERABILITY OF THE AG200-15 TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM (TCDS) (P&S Industry Clinical Trial)
Dec 16 2014 - Dec 16 2019
AMULTI-CENTER, MULTI-NATIONAL CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE ESSURE? (MODEL ESS505) DEVICE TO PREVENT PREGNANCY IN WOMEN WHO ARE SEEKING PERMANENT CONTRACEPTION (P&S Industry Clinical Trial)
Mar 11 2014 - Mar 11 2019
AMULTICENTER, OPEN LABEL RANDOMIZED STUDY ON THE EFFICACY, CYCLE CONTROL AND SAFETY OF A CONTRACEPTIVE VAGINAL RING DELIVERING A DAILY DOSE OF NESTORONE AND ESTRADIOL (NES E2 CVR) (Federal Gov)
Sep 25 2015 - Sep 24 2018
APHASE III, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED, MULTI-CENTER TRIAL TO STUDY THE CONTRACEPTIVE EFFICACY AND SAFETY OF THE COMMERCIAL BATCH OF ORAL TABLESTS OF MK-8175A (NOMEGESTROL ACETATE 17BESTRADIOL) (P&S Industry Clinical Trial)
Feb 14 2013 - Feb 14 2018
COLUMBIA UNIVERSITY CISA CENTER (Federal Gov)
Sep 27 2012 - Sep 26 2017
AMULTICENTER, OPEN LABEL RANDOMIZED STUDY ON THE EFFICACY, CYCLE CONTROL AND SAFETY OF A CONTRACEPTIVE VAGINAL RING DELIVERING A DAILY DOSE OF NESTORONE AND ESTRADIOL (NES E2 CVR) (Federal Gov)
Sep 19 2014 - Sep 18 2017
CENTRAL LAB FOR THE NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CONTRACEPTION (Federal Gov)
Mar 31 2011 - Oct 31 2014
A RETROSPECTIVE EVALUATION OF WOMEN UNDERGOING MIRENA INSERTION THROUGHOUT THE MENSTRUAL CYCLE (Private)
Feb 15 2013 - Aug 15 2014
TEXTFLUENZA: USING TECHNOLOGY TO PROMOTE FLU VACCINATION IN UNDERSERVED MATERNAL AND CHILD POPULATIONS (Federal Gov)
Feb 1 2010 - Jan 31 2014
TEXTFLUENZA: USING TECHNOLOGY TO PROMOTE FLU VACCINATION IN UNDERSERVED MATERNAL AND CHILD POPULATIONS (Federal Gov)
Feb 1 2010 - Jan 31 2014
CONTRACEPTIVE RESEARCH AND TRAINING (Private)
Jul 1 2007 - Jun 30 2013
CONTRACEPTIVE EFFICACY EVALUATION OF THE PATH FEMALE CONDOM (Federal Gov)
Sep 30 2009 - Dec 31 2012
OB GYN FAMILY PLANNING PASSTHRU (NY State Gov)
Jan 1 2009 - Dec 31 2012
PRENATAL BLOOD TEST FOR FETAL ANEUPLOIDY DETECTION (PROTOCOL TDX-002) (Private)
Dec 14 2010 - Dec 31 2012
MUSIC AS AN AUXILIARY ANALGESIC AND ANXIOLYTIC DURING FIRST TRIMESTER ABORTION (Private)
Jun 1 2009 - Jun 30 2011
AFFINITYHEALTH GRANT (P&S Industry Clinical Trial)
Aug 1 2007 - Sep 30 2010
For a complete list of publications, please visit PubMed.gov
Related News
-
Source:
Well and GoodFebruary 23, 2019Topic
-
Source:
Yahoo LifestyleSeptember 5, 2018Topic
